| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 7,858 | 88,346,347 | -0.35% | -1.22% | 3.49% | 2.07% | 11.19% | 18.98% |
| Healthcare | HEALTHCARE | Sector | 1,180 | 8,116,976 | -0.15% | 4.15% | 7.63% | 16.55% | 12.88% | 30.59% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 583 | 4,610,788 | -0.20% | 5.36% | 7.69% | 17.37% | 17.26% | 53.67% |
| Other Biopharmaceuticals | BIOPHARMAOTHER | Industry | 101 | 1,741,526 | 0.43% | 4.64% | 7.00% | 19.89% | 11.72% | 41.20% |
| Toxicology Biopharmaceuticals | TOXICOLOGY | SubInd | 9 | 6,119 | -1.23% | -3.91% | -3.06% | 5.97% | 20.09% | -0.84% |
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | AQST:USAAQST:USA | Stock | 1 | 602 | 3.00% | 11.89% | 30.43% | 17.65% | 17.36% | 20.60% |
| Achieve Life Sciences, Inc. | ACHV:USAACHV:USA | Stock | 1 | 815 | -0.63% | 5.87% | 30.16% | 74.12% | 80.87% | 171.92% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,046 | 111,424,542 | -0.29% | -1.19% | 3.32% | 1.98% | 11.66% | 19.62% |
| Toxicology Biopharmaceuticals | TOXICOLOGY | SubInd | 9 | 6,119 | -1.23% | -3.91% | -3.06% | 5.97% | 20.09% | -0.84% |
| Indivior Pharmaceuticals, Inc. | INDV:USAINDV:USA | Stock | 1 | 4,270 | -1.87% | -7.42% | -10.72% | -4.31% | 9.44% | 48.77% |
* Colors indicate performance relative to the benchmark.